BusinessEli Lilly, Mubadala Bio Plan Abu Dhabi Packaging for GLP-1 MedicinesBy Helena WardOct 21, 2026, 12:17 AM UTC
HealthLilly Reports 50% Remission at Week 52 Among Pediatric Omvoh RespondersBy Naomi CalderOct 19, 2026, 2:51 PM UTC
HealthLilly Highlights Four Oncology Data Sets for October ESMO CongressBy Naomi CalderOct 18, 2026, 10:17 PM UTC
InvestingThree Non-Chip Stocks Gain as Semiconductor ETF Extends Its Losing RunBy Celia RowanOct 16, 2026, 2:41 PM UTC
BusinessFinalists Announced for 2018 Diabetes Innovation ChallengeBy Nasdaq OMXApr 24, 2018, 12:10 PM UTC
BusinessINVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKSBy Nasdaq OMXDec 13, 2017, 6:13 PM UTC
BusinessCrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research ProgramsBy Nasdaq OMXNov 21, 2017, 1:00 PM UTC
